Tenecteplase for Acute Ischemic Stroke
Intravenous thrombolytics is the mainstay of acute therapy in ischemic stroke.  While alteplase has been FDA-approved for this indication since the 1990s, Tenecteplase has recently gained traction for usage in acute ischemic stroke treatment as well.  This lecture summarizes the existing evidence
Category
  • CME Activities
  • Critical Care
  • Emergency
  • Neurology
  • Stroke
  • Tenecteplase
  • Thrombolytics
Format
  • Self-study / Enduring
Credits
  • Participation

Pages